Motilal Oswal 's research report on Shree Cement
Shree Cement (SCRM)’s 1QFY21 result was relatively weaker than large-cap peers (UTCEM, Ambuja) as EBITDA/t declined to INR1421/t v/s sharp expansion reported by peers. While we keep our estimates largely unchanged, we see challenges related to near-term margins for SRCM. These pertain to the hike in cost, but decline in price in its operating regions. The balance sheet should, however, strengthen further (~INR33b net cash) on limited capex under execution. We maintain Neutral as the current valuation (16.8x FY22E EV/EBITDA) does not offer any upside.
Outlook
We value SCRM at 16x FY22E EV/EBITDA and add the value of the UAE operations at USD70/t to arrive at TP of INR21,500. We expect EBITDA to grow at just a 6% CAGR over FY20–22E, lower than large-cap peers. We therefore rate it as Neutral. The stock trades at 16.8x FY22E EV/EBITDA.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.